Möchten Sie immer auf dem neuesten Stand bleiben?

Facephi Ranks No. 1 in Biometric & Document Authentication Capabilities in the Identity Platform Category by The Prism Project #1 in Biometric & Document Authentication Capabilities within...

AUSTIN, Texas, Dec. 09, 2025 (GLOBE NEWSWIRE) -- SEON, the command center for real-time fraud prevention and AML compliance, has earned three AWS (Amazon Web Services) Competencies based on proven...

Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue™, AMX-883, to transform the treatment paradigm for acute myeloid leukaemia AMX-883-induced BRD9...

FOR IMMEDIATE RELEASE -- ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ASH 2025 -- Updated clinical data presented at ASH show robust efficacy,...

Designed with our proprietary AI-Immunology™ platform based on patient sequencing data, EVX-04 targets multiple non-conventional endogenous retrovirus (ERV) tumor antigensEVX-04 induces targeted...

ImCheck Announces Oral Presentation of ICT01 First-Line AML Data at the 67th ASH Annual Meeting Marseille, France, December 5, 2025 05:00 a.m. ET / 11:00 a.m. CET– ImCheck Therapeutics announced...

Quantexa named Category Leader by Chartis for AML & KYC, recognized for AI, data integration, and risk intelligence in banking.

AUSTIN, Texas, Nov. 18, 2025 (GLOBE NEWSWIRE) -- SEON, the command center for real-time fraud prevention and AML compliance, today announced the expansion of its platform with advanced capabilities...

APOLLO study showed encouraging overall responses and favorable safety profile in relapsed/refractory B-cell lymphoma  MT-601 demonstrated 66% objective response rate with 50% complete response in...

Aptose Reports Third Quarter 2025 Results